Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5
Original Research
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,653 | Dovepress* | 5,101+ | 827 | 5,928 | |
| PubMed Central* | 552 | 130 | 682 | ||
| Totals | 5,653 | 957 | 6,610 | ||
| *Since 19 November 2018 | |||||
View citations on PubMed Central and Google Scholar